Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DPAG is among the departments receiving funding from the University's research respond fund to undertake COVID-19 research. As part of this effort, the Swietach lab has been studying oxygen transport in the blood of COVID-19 patients.

One grey square with yellow dots inside and a white square with a K ,T and S in brackets as a formula © DPAG

The first results of this study are now published in the British Journal of Haematology and could pave the way for new guidelines for treating the virus.

In the early days of the pandemic, clinicians were puzzled by the dangerously low levels of oxygen measured in those COVID-19 patients who have apparently normal lung mechanics. In response to this finding, a myriad of speculations have emerged, ostensibly implicating a problem with red blood cells (RBCs), the blood-borne carriers of oxygen. Indeed, inadequate oxygen transport by RBCs would manifest as hypoxia even with normal lung function, but critically, these patients would not necessarily benefit from supplemental oxygen on a ventilator.

Read the full article (DPAG website)